Cargando…

Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife

PURPOSE: For the treatment of invisible lung tumours with CyberKnife (CK), fiducial markers (FMs) were implanted as an internal surrogate under virtual bronchoscopic navigation (VBN). This research aims to study the benefits of introducing an additional procedure in assigning the optimal FM position...

Descripción completa

Detalles Bibliográficos
Autores principales: Ku, Ki Man, Lam, Bing, Wu, Vincent W. C., Chan, Kwok Ting, Chan, Chloe Y. Y., Cheng, H. C., Yuen, Kamy M. Y., Cai, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246503/
https://www.ncbi.nlm.nih.gov/pubmed/35785178
http://dx.doi.org/10.3389/fonc.2022.860641
_version_ 1784738983099498496
author Ku, Ki Man
Lam, Bing
Wu, Vincent W. C.
Chan, Kwok Ting
Chan, Chloe Y. Y.
Cheng, H. C.
Yuen, Kamy M. Y.
Cai, Jing
author_facet Ku, Ki Man
Lam, Bing
Wu, Vincent W. C.
Chan, Kwok Ting
Chan, Chloe Y. Y.
Cheng, H. C.
Yuen, Kamy M. Y.
Cai, Jing
author_sort Ku, Ki Man
collection PubMed
description PURPOSE: For the treatment of invisible lung tumours with CyberKnife (CK), fiducial markers (FMs) were implanted as an internal surrogate under virtual bronchoscopic navigation (VBN). This research aims to study the benefits of introducing an additional procedure in assigning the optimal FM positions using a pre-procedure planning system and performing virtual simulation before implantation. The objectives were 1) to reduce the duration of the FM implantation procedure, 2) to reduce the radiation exposure in dose area product (DAP) (dGy*cm(2)) to patients, and 3) to increase the number of FMs implanted around the tumour. METHODS AND MATERIALS: This study is retrospective, single-centre, and observational in nature. A total of 32 patients were divided into two groups. In Group 1, 18 patients underwent conventional VBN FM implantation. In Group 2, 14 patients underwent additional pre-procedure planning and simulation. The steps of pre-procedure planning include 1) importing CT images into the treatment planning system (Eclipse, Varian Medical Systems, Inc.) and delineating five to six FMs in their ideal virtual positions and 2) copying the FM configuration into VBN planning software (LungPoint Bronchus Medical, Inc.) for verification and simulation. Finally, the verified FMs were deployed through VBN with the guidance of the LungPoint planning software. RESULTS: A total of 162 FMs were implanted among 35 lesions in 32 patients aged from 37 to 92 (median = 66; 16 men and 16 women). Results showed that 1) the average FM insertion time was shortened from 41 min (SD = 2.05) to 23 min (SD = 1.25), p = 0.00; 2) the average absorbed dose of patients in DAP was decreased from 67.4 cGy*cm(2) (SD = 14.48) to 25.3 cGy*cm(2) (SD = 3.82), p = 0.01 (1-tailed); and 3) the average number of FMs implanted around the tumour was increased from 4.7 (SD = 0.84) to 5.6 (SD = 0.76), p = 0.00 (1-tailed). CONCLUSION: Pre-procedure planning reduces the FM implantation duration from 41.1 to 22.9 min, reduces the radiation exposure in DAP from 67.4 to 25.3 dGy*cm(2), and increases the number of FMs inserted around the tumour from 4.7 to 5.6.
format Online
Article
Text
id pubmed-9246503
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92465032022-07-01 Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife Ku, Ki Man Lam, Bing Wu, Vincent W. C. Chan, Kwok Ting Chan, Chloe Y. Y. Cheng, H. C. Yuen, Kamy M. Y. Cai, Jing Front Oncol Oncology PURPOSE: For the treatment of invisible lung tumours with CyberKnife (CK), fiducial markers (FMs) were implanted as an internal surrogate under virtual bronchoscopic navigation (VBN). This research aims to study the benefits of introducing an additional procedure in assigning the optimal FM positions using a pre-procedure planning system and performing virtual simulation before implantation. The objectives were 1) to reduce the duration of the FM implantation procedure, 2) to reduce the radiation exposure in dose area product (DAP) (dGy*cm(2)) to patients, and 3) to increase the number of FMs implanted around the tumour. METHODS AND MATERIALS: This study is retrospective, single-centre, and observational in nature. A total of 32 patients were divided into two groups. In Group 1, 18 patients underwent conventional VBN FM implantation. In Group 2, 14 patients underwent additional pre-procedure planning and simulation. The steps of pre-procedure planning include 1) importing CT images into the treatment planning system (Eclipse, Varian Medical Systems, Inc.) and delineating five to six FMs in their ideal virtual positions and 2) copying the FM configuration into VBN planning software (LungPoint Bronchus Medical, Inc.) for verification and simulation. Finally, the verified FMs were deployed through VBN with the guidance of the LungPoint planning software. RESULTS: A total of 162 FMs were implanted among 35 lesions in 32 patients aged from 37 to 92 (median = 66; 16 men and 16 women). Results showed that 1) the average FM insertion time was shortened from 41 min (SD = 2.05) to 23 min (SD = 1.25), p = 0.00; 2) the average absorbed dose of patients in DAP was decreased from 67.4 cGy*cm(2) (SD = 14.48) to 25.3 cGy*cm(2) (SD = 3.82), p = 0.01 (1-tailed); and 3) the average number of FMs implanted around the tumour was increased from 4.7 (SD = 0.84) to 5.6 (SD = 0.76), p = 0.00 (1-tailed). CONCLUSION: Pre-procedure planning reduces the FM implantation duration from 41.1 to 22.9 min, reduces the radiation exposure in DAP from 67.4 to 25.3 dGy*cm(2), and increases the number of FMs inserted around the tumour from 4.7 to 5.6. Frontiers Media S.A. 2022-06-16 /pmc/articles/PMC9246503/ /pubmed/35785178 http://dx.doi.org/10.3389/fonc.2022.860641 Text en Copyright © 2022 Ku, Lam, Wu, Chan, Chan, Cheng, Yuen and Cai https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ku, Ki Man
Lam, Bing
Wu, Vincent W. C.
Chan, Kwok Ting
Chan, Chloe Y. Y.
Cheng, H. C.
Yuen, Kamy M. Y.
Cai, Jing
Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife
title Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife
title_full Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife
title_fullStr Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife
title_full_unstemmed Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife
title_short Clinical Evaluation of Fiducial Marker Pre-Planning for Virtual Bronchoscopic Navigation Implantation in Lung Tumour Patients Treated With CyberKnife
title_sort clinical evaluation of fiducial marker pre-planning for virtual bronchoscopic navigation implantation in lung tumour patients treated with cyberknife
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246503/
https://www.ncbi.nlm.nih.gov/pubmed/35785178
http://dx.doi.org/10.3389/fonc.2022.860641
work_keys_str_mv AT kukiman clinicalevaluationoffiducialmarkerpreplanningforvirtualbronchoscopicnavigationimplantationinlungtumourpatientstreatedwithcyberknife
AT lambing clinicalevaluationoffiducialmarkerpreplanningforvirtualbronchoscopicnavigationimplantationinlungtumourpatientstreatedwithcyberknife
AT wuvincentwc clinicalevaluationoffiducialmarkerpreplanningforvirtualbronchoscopicnavigationimplantationinlungtumourpatientstreatedwithcyberknife
AT chankwokting clinicalevaluationoffiducialmarkerpreplanningforvirtualbronchoscopicnavigationimplantationinlungtumourpatientstreatedwithcyberknife
AT chanchloeyy clinicalevaluationoffiducialmarkerpreplanningforvirtualbronchoscopicnavigationimplantationinlungtumourpatientstreatedwithcyberknife
AT chenghc clinicalevaluationoffiducialmarkerpreplanningforvirtualbronchoscopicnavigationimplantationinlungtumourpatientstreatedwithcyberknife
AT yuenkamymy clinicalevaluationoffiducialmarkerpreplanningforvirtualbronchoscopicnavigationimplantationinlungtumourpatientstreatedwithcyberknife
AT caijing clinicalevaluationoffiducialmarkerpreplanningforvirtualbronchoscopicnavigationimplantationinlungtumourpatientstreatedwithcyberknife